Unknown

Dataset Information

0

Serum sCD14, PGLYRP2 and FGA as potential biomarkers for multidrug-resistant tuberculosis based on data-independent acquisition and targeted proteomics.


ABSTRACT: Multidrug-resistant tuberculosis (MDR-TB), defined as tuberculosis (TB) resistant to at least isoniazid and rifampicin, is a major concern of TB control worldwide. However, the diagnosis of MDR-TB remains a huge challenge to its prevention and control. To identify new diagnostic methods for MDR-TB, a mass spectrometry strategy of data-independent acquisition and parallel reaction monitoring was used to detect and validate differential serum proteins. The bioinformatic analysis showed that the functions of differential serum proteins between the MDR-TB group and the drug-sensitive tuberculosis group were significantly correlated to the complement coagulation cascade, surface adhesion and extracellular matrix receptor interaction, suggesting a disorder of coagulation in TB. Here, we identified three potential candidate biomarkers such as sCD14, PGLYRP2 and FGA, and established a diagnostic model using these three candidate biomarkers with a sensitivity of 81.2%, a specificity of 90% and the area under the curve value of 0.934 in receiver operation characteristics curve to diagnose MDR-TB. Our study has paved the way for a novel method to diagnose MDR-TB and may contribute to elucidate the mechanisms underlying MDR-TB.

SUBMITTER: Chen J 

PROVIDER: S-EPMC7686995 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Serum sCD14, PGLYRP2 and FGA as potential biomarkers for multidrug-resistant tuberculosis based on data-independent acquisition and targeted proteomics.

Chen Jing J   Han Yu-Shuai YS   Yi Wen-Jing WJ   Huang Huai H   Li Zhi-Bin ZB   Shi Li-Ying LY   Wei Li-Liang LL   Yu Yi Y   Jiang Ting-Ting TT   Li Ji-Cheng JC  

Journal of cellular and molecular medicine 20200923 21


Multidrug-resistant tuberculosis (MDR-TB), defined as tuberculosis (TB) resistant to at least isoniazid and rifampicin, is a major concern of TB control worldwide. However, the diagnosis of MDR-TB remains a huge challenge to its prevention and control. To identify new diagnostic methods for MDR-TB, a mass spectrometry strategy of data-independent acquisition and parallel reaction monitoring was used to detect and validate differential serum proteins. The bioinformatic analysis showed that the fu  ...[more]

Similar Datasets

| S-EPMC7187936 | biostudies-literature
| S-EPMC5924490 | biostudies-literature
| S-EPMC8283568 | biostudies-literature
| S-EPMC9764215 | biostudies-literature
| S-EPMC4563719 | biostudies-literature
| S-EPMC5925839 | biostudies-literature
| S-EPMC9678856 | biostudies-literature
| S-EPMC7052258 | biostudies-literature
| S-EPMC5462478 | biostudies-literature
| S-EPMC5517573 | biostudies-literature